Literature DB >> 7733182

Prognosis of stage 2 macular holes.

T Hikichi1, A Yoshida, J Akiba, S Konno, C L Trempe.   

Abstract

PURPOSE: We ascertained the natural course of stage 2 idiopathic macular holes to determine better treatment possibilities.
METHODS: We reviewed 48 eyes with stage 2 idiopathic macular holes and followed them up for more than two years. At each examination, best-corrected Snellen visual acuity was measured by a physician masked to the hypothesis of the study.
RESULTS: Stage 2 lesions progressed to stage 3 or 4 during the follow-up period in 32 (67%) and 14 (29%) of 48 eyes, respectively; two eyes (4%) remained in stage 2. In 41 (85%) of 48 eyes, the hole size enlarged during the follow-up: 32 (94%) of 34 eyes had vitreomacular attachment and nine (64%) of 14 eyes had vitreomacular separation at the final examination, for a statistically significant difference in prevalence (P = .03). Visual acuity decreased two or more Snellen lines during the follow-up period in 34 (71%) of 48 eyes, the prevalence of which was significantly higher in eyes with vitreomacular attachment at the final examination (28 of 34, 82%) than in eyes with vitreomacular separation at the final examination (six of 14, 43%) (P = .01).
CONCLUSION: Even though vitreomacular separation may improve the prognosis of a macular hole, stage 2 lesions usually will develop an enlarged hole and decreased visual acuity.

Entities:  

Mesh:

Year:  1995        PMID: 7733182     DOI: 10.1016/s0002-9394(14)70214-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  12 in total

Review 1.  Idiopathic full thickness macular hole: natural history and pathogenesis.

Authors:  E Ezra
Journal:  Br J Ophthalmol       Date:  2001-01       Impact factor: 4.638

2.  Macular microholes: pathogenesis and natural history.

Authors:  H J Zambarakji; P Schlottmann; V Tanner; A Assi; Z J Gregor
Journal:  Br J Ophthalmol       Date:  2005-02       Impact factor: 4.638

3.  Spectral domain optical coherence tomography study of macular microhole morphology and its correlation with vitreomacular interface abnormalities.

Authors:  Batmanabane Prakash Vaishnavi; Unnikrishnan Nair; Manoj Soman; K G R Nair
Journal:  Int Ophthalmol       Date:  2013-08-09       Impact factor: 2.031

4.  Natural outcomes of stage 1, 2, 3, and 4 idiopathic macular holes.

Authors:  J Ferris
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

5.  Spontaneous resolution of grade 2 macular hole observed with optical coherence tomography.

Authors:  Sachet Prabhat Shrestha; Reema Arora
Journal:  BMJ Case Rep       Date:  2010-11-29

6.  Differentiating full thickness macular holes from impending macular holes and macular pseudoholes.

Authors:  M Tsujikawa; M Ohji; T Fujikado; Y Saito; M Motokura; I Ishimoto; Y Tano
Journal:  Br J Ophthalmol       Date:  1997-02       Impact factor: 4.638

7.  Types of macular hole closure and their clinical implications.

Authors:  S W Kang; K Ahn; D-I Ham
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

8.  Treatment of idiopathic macular hole with silicone oil tamponade.

Authors:  Biljana Ivanovska-Adjievska; Salih Boskurt; Faruk Semiz; Hakan Yuzer; Vesna Dimovska-Jordanova
Journal:  Clin Ophthalmol       Date:  2012-08-06

9.  Prognostic Factors Associated with Ocriplasmin Efficacy for the Treatment of Symptomatic Vitreomacular Adhesion and Full-thickness Macular Hole: Analysis from Four Studies.

Authors:  Brian C Joondeph; Paul Willems; Thomas Raber; Luc Duchateau; Joseph Markoff
Journal:  J Ophthalmic Vis Res       Date:  2021-01-20

10.  ASSESSMENT OF ANATOMICAL AND FUNCTIONAL OUTCOMES WITH OCRIPLASMIN TREATMENT IN PATIENTS WITH VITREOMACULAR TRACTION WITH OR WITHOUT MACULAR HOLES: Results of OVIID-1 Trial.

Authors:  Ramin Tadayoni; Frank G Holz; Christophe Zech; Xin Liu; Claudio Spera; Peter Stalmans
Journal:  Retina       Date:  2019-12       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.